Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

New Market Study Published: Spinocerebellar Ataxias - Pipeline Review, H2 2013


Print article Print article
2014-01-27 08:15:39 - Recently published research from Global Markets Direct, "Spinocerebellar Ataxias - Pipeline Review, H2 2013", is now available at Fast Market Research

Global Markets Direct's, 'Spinocerebellar Ataxias - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Spinocerebellar Ataxias, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Spinocerebellar Ataxias. Spinocerebellar Ataxias - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated

disease.

Scope

* A snapshot of the global therapeutic scenario for Spinocerebellar Ataxias.
* A review of the Spinocerebellar Ataxias products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Spinocerebellar Ataxias pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Full Report Details at
- www.fastmr.com/prod/769226_spinocerebellar_ataxias_pipeline_revi ..

Reasons to Get this Report

* Identify and understand important and diverse types of therapeutics under development for Spinocerebellar Ataxias.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Spinocerebellar Ataxias pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies Mentioned in this Report: Kissei Pharmaceutical Co., Ltd., Vybion, Inc.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Spinocerebellar Ataxias Overview
Therapeutics Development
Pipeline Products for Spinocerebellar Ataxias - Overview
Pipeline Products for Spinocerebellar Ataxias - Comparative Analysis
Spinocerebellar Ataxias - Therapeutics under Development by Companies
Spinocerebellar Ataxias - Therapeutics under Investigation by Universities/Institutes
Spinocerebellar Ataxias - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Spinocerebellar Ataxias - Products under Development by Companies
Spinocerebellar Ataxias - Products under Investigation by Universities/Institutes
Spinocerebellar Ataxias - Companies Involved in Therapeutics Development
Kissei Pharmaceutical Co., Ltd.
Vybion, Inc.
Spinocerebellar Ataxias - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Assessment by Therapeutic Class
Drug Profiles
KPS-0373 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
lithium carbonate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
lithium carbonate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
shAtx3 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
INT-41 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Spinocerebellar Ataxias - Recent Pipeline Updates
Spinocerebellar Ataxias - Dormant Projects
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Spinocerebellar Ataxias, H2 2013
Number of Products under Development for Spinocerebellar Ataxias - Comparative Analysis, H2 2013
Number of Products under Development by Companies, H2 2013
Number of Products under Investigation by Universities/Institutes, H2 2013
Comparative Analysis by Late Stage Development, H2 2013
Comparative Analysis by Clinical Stage Development, H2 2013
Comparative Analysis by Early Stage Development, H2 2013
Products under Development by Companies, H2 2013
Products under Investigation by Universities/Institutes, H2 2013
Spinocerebellar Ataxias - Pipeline by Kissei Pharmaceutical Co., Ltd., H2 2013
Spinocerebellar Ataxias - Pipeline by Vybion, Inc., H2 2013
Assessment by Monotherapy Products, H2 2013
Number of Products by Stage and Target, H2 2013
Number of Products by Stage and Mechanism of Action, H2 2013
Number of Products by Stage and Route of Administration, H2 2013
Number of Products by Stage and Molecule Type, H2 2013
Number of Products by Stage and Therapeutic Class, H2 2013
Spinocerebellar Ataxias Therapeutics - Recent Pipeline Updates, H2 2013
Spinocerebellar Ataxias - Dormant Projects, H2 2013

List of Figures
Number of Products under Development for Spinocerebellar Ataxias, H2 2013

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=769226&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com